MedPath

APRI

Apri (desogestrel and ethinyl estradiol) Tablets

Approved
Approval ID

f3d91179-27e3-4bac-be47-8f224c836f5f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 24, 2011

Manufacturers
FDA

Physicians Total Care, Inc.

DUNS: 194123980

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Desogestrel and Ethinyl Estradiol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54868-4754
Application NumberANDA075256
Product Classification
M
Marketing Category
C73584
G
Generic Name
Desogestrel and Ethinyl Estradiol
Product Specifications
Effective DateApril 13, 2011
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

APRI - FDA Drug Approval Details